Metraipolis › archive › dc_7bdf6c7144fc

Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study — Europe PMC PMID:41194091

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41194091
DOI: 10.1186/s13058-[numero omesso]-1
License (as archived): solo-consultazione
Archived: 2026-11-08T19:10:53.531Z
SHA-256 of the archived text: a905cc83c99dee182aae03b84c68263a343051b758e33a16c654dab0dc30b825
Stable URL of this page: https://metraipolis.com/documento/dc_7bdf6c7144fc

How to cite

Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study — Europe PMC PMID:41194091 — Europe PMC (en), https://europepmc.org/article/MED/41194091 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bdf6c7144fc (Metraipolis archive dc_7bdf6c7144fc, sha256 a905cc83c99dee182aae03b84c68263a343051b758e33a16c654dab0dc30b825)

BibTeX

@misc{dc7bdf6c7144fc,
  title = {Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study — Europe PMC PMID:41194091},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41194091},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bdf6c7144fc; sha256 a905cc83c99dee182aae03b84c68263a343051b758e33a16c654dab0dc30b825},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194091. Agents can read the archived copy with the MCP tool read_document.